特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959778

抗高血圧薬の世界市場:Covid-19の影響と回復、2020年~2030

Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
抗高血圧薬の世界市場:Covid-19の影響と回復、2020年~2030
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の抗高血圧薬市場を調査したもので、国別、地域別の分析、競合情勢と企業プロファイル、合併と買収の動き、市場のトレンドや戦略、製品パイプライン分析、今後の展望や成長性の分析を通じ、最大の市場と急成長している市場、全般的な景気動向や人口動態、他の隣接市場との関連、今後市場の方向性を決定づける要因などを明らかにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特性

第3章 市場規模と成長性

  • 市場の実績
    • 市場の成長要因
    • 市場の抑制要因
  • 市場の予測
    • 市場の成長要因
    • 市場の抑制要因

第4章 市場区分

  • 治療薬別の実績と予測
    • 利尿薬
    • アンジオテンシン受容体遮断薬(ARB)
    • アンジオテンシン変換酵素(ACE)阻害剤
    • ベータ遮断薬
    • アルファ遮断薬
    • カルシウムチャンネル遮断薬
    • レニン阻害剤
    • 血管拡張薬
  • 病因別の実績と予測
    • 原発性高血圧
    • 二次性高血圧
  • エンドユーザー別の実績と予測
    • 病院
    • クリニック
    • 在宅治療

第5章 地域別、国別の分析

  • 地域別の実績と予測
  • 国別の実績と予測

第6章 アジア太平洋市場

  • 市場の概要
  • 治療薬別の実績と予測
  • エンドユーザー別の実績と予測

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧市場

第18章 ロシア市場

第19章 北米市場

第20章 米国市場

第21章 南米市場

第22章 ブラジル市場

第23章 中東市場

第24章 アフリカ市場

第25章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Merck & Co. Inc.
    • Astra Zeneca Plc
    • Daiichi Sankyo Company Limited
    • Johnson & Johnson Ltd.
    • Pfizer, Inc.

第26章 主な合併と買収

第27章 市場の動向と戦略

第28章 製品パイプライン分析

第29章 将来の展望と成長性の分析

第30章 付録

目次

Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global anti-hypertensive drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the anti-hypertensive drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Hypertensive Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators

2) By Disease source: Primary Hypertension; Secondary Hypertension

3) By End users: Hospitals; Clinics; Homecare

Companies Mentioned: Merck & Co.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anti-Hypertensive Drugs Market Characteristics

3. Anti-Hypertensive Drugs Market Size And Growth

  • 3.1. Global Anti-Hypertensive Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anti-Hypertensive Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anti-Hypertensive Drugs Market Segmentation

  • 4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Diuretics
    • Angiotensin Receptor Blockers (ARBs)
    • Angiotensin Converting Enzyme (ACE) Inhibitors
    • Beta Blockers
    • Alpha Blockers
    • Calcium Channel Blockers
    • Renin Inhibitors
    • Vasodilators
  • 4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Primary Hypertension
    • Secondary Hypertension
  • 4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Homecare

5. Anti-Hypertensive Drugs Market Regional And Country Analysis

  • 5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-Hypertensive Drugs Market

  • 6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview
  • 6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Anti-Hypertensive Drugs Market

  • 7.1. China Anti-Hypertensive Drugs Market Overview
  • 7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Anti-Hypertensive Drugs Market

  • 8.1. India Anti-Hypertensive Drugs Market Overview
  • 8.2. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Anti-Hypertensive Drugs Market

  • 9.1. Japan Anti-Hypertensive Drugs Market Overview
  • 9.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Anti-Hypertensive Drugs Market

  • 10.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Anti-Hypertensive Drugs Market

  • 11.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Anti-Hypertensive Drugs Market

  • 12.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Anti-Hypertensive Drugs Market

  • 13.1. Western Europe Anti-Hypertensive Drugs Market Overview
  • 13.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Anti-Hypertensive Drugs Market

  • 14.1. UK Anti-Hypertensive Drugs Market Overview
  • 14.2. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Anti-Hypertensive Drugs Market

  • 15.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Anti-Hypertensive Drugs Market

  • 16.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-Hypertensive Drugs Market

  • 17.1. Eastern Europe Anti-Hypertensive Drugs Market Overview
  • 17.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Anti-Hypertensive Drugs Market

  • 18.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Anti-Hypertensive Drugs Market

  • 19.1. North America Anti-Hypertensive Drugs Market Overview
  • 19.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Anti-Hypertensive Drugs Market

  • 20.1. USA Anti-Hypertensive Drugs Market Overview
  • 20.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Anti-Hypertensive Drugs Market

  • 21.1. South America Anti-Hypertensive Drugs Market Overview
  • 21.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Anti-Hypertensive Drugs Market

  • 22.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Anti-Hypertensive Drugs Market

  • 23.1. Middle East Anti-Hypertensive Drugs Market Overview
  • 23.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Anti-Hypertensive Drugs Market

  • 24.1. Africa Anti-Hypertensive Drugs Market Overview
  • 24.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Anti-Hypertensive Drugs Market Competitive Landscape
  • 25.2. Anti-Hypertensive Drugs Market Company Profiles
    • 25.2.1. Merck & Co. Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Astra Zeneca Plc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Daiichi Sankyo Company Limited
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Johnson & Johnson Ltd.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Pfizer, Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market

27. Anti-Hypertensive Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.